Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

iwNHL 10: Advances in the treatment of lymphoma

Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Dr Myron Czuczman - Roswell Park Cancer Institute, Buffalo, NY, USA; Professor Michael Pfreundschuh - University of Saarland, Homburg-Saar, Germany; Prof John Gribben - Bart’s and Royal
iwNHL 10: Advances in the treatment of lymphoma ( Dr Wyndham Wilson -  National Cancer Institute, Bethesda, MD, USA;  Dr Myron Czuczman -  Roswell Park Cancer Institute, Buffalo, NY, USA;  Professor Michael Pfreundschuh - University of Saarland, Homburg-Saar, Germany; Prof John Gribben - Bart’s and Royal )
26 Sep 2012

Molecular stratification of breast cancer: reaching the clinic

Prof Carlos Caldas - University of Cambridge, UK
Molecular stratification of breast cancer: reaching the clinic ( Prof Carlos Caldas - University of Cambridge, UK )
25 Jul 2012

The immuno side of melanoma

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
The immuno side of melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
16 Jul 2012

Highlights of the 22nd EACR meeting and tackling glioblastoma

Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012

Strategies to improve the tolerability of treatment in patients with multiple myeloma

Prof Michel Delforge - Catholic University, Leuven, Belgium
Strategies to improve the tolerability of treatment in patients with multiple myeloma ( Prof Michel Delforge - Catholic University, Leuven, Belgium )
13 Jul 2012

EHA 2012 advances in lymphoma; lenalidamide and beyond

Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Gilles Salles - Universite Claude Bernard, Lyon, France
EHA 2012 advances in lymphoma; lenalidamide and beyond ( Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Gilles Salles - Universite Claude Bernard, Lyon, France )
29 Jun 2012

New drugs for relapsed and refractory Hodgkin's lymphoma

Prof Anas Younes - MD Anderson Cancer Center, Houston, USA
New drugs for relapsed and refractory Hodgkin's lymphoma ( Prof Anas Younes - MD Anderson Cancer Center, Houston, USA )
22 Jun 2012

How malignant cells in patients with CLL escape T-cell recognition

Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK
How malignant cells in patients with CLL escape T-cell recognition ( Dr Alan G Ramsay - Barts Cancer Institute, Queen Mary University of London, UK )
22 Jun 2012

Impressive results with a bispecific antibody for ALL

Prof Max Topp - University of Wuerzberg, Germany
Impressive results with a bispecific antibody for ALL ( Prof Max Topp - University of Wuerzberg, Germany )
21 Jun 2012

Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy

Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA
Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )
19 Jun 2012

ASCO 2012 Drug Development Research Professorship

Dr Alex Adjei - Roswell Park Cancer Institute, Las Vegas, USA
ASCO 2012 Drug Development Research Professorship ( Dr Alex Adjei - Roswell Park Cancer Institute, Las Vegas, USA )
18 Jun 2012

Acute Lymphocytic Leukemia: impressive results with a bispecific antibody in patients with refractory disease

Prof Max Topp - University of Wuerzberg, Germany
Acute Lymphocytic Leukemia: impressive results with a bispecific antibody in patients with refractory disease ( Prof Max Topp - University of Wuerzberg, Germany )
15 Jun 2012